Navigation Links
Boehringer Ingelheim to Sponsor the Bonnie J. Addario Lung Cancer Foundation's Efforts to Promote Genetic Biomarker Testing
Date:11/7/2013

m Pharmaceuticals, Inc. "It's about a more detailed diagnosis as early as possible to help physicians more immediately match each patient with the most appropriate course of treatment."

The sponsorship from BI to promote genetic biomarker testing in advanced NSCLC also complements ALCF's Patient 360 Community Hospital Program that aims to create a new standard of care for lung cancer patients in the community hospital setting. One of the requirements of the ALCF's Patient 360 Community Hospital Program is administering genetic biomarker testing for all patients in the Program.

While the understanding of the diagnosis and treatment of lung cancer has improved, there is additional work to be done. In 2013 alone, more than 228,000 new cases of lung cancer will be diagnosed in the U.S., and the American Cancer Society estimates nearly 160,000 Americans will die of the disease.1

The facts about lung cancer cannot continue to go unnoticed:

  • Lung cancer takes more lives than breast, prostate and colon cancers combined and it accounts for 27 percent of all cancer deaths.1 It is the second leading cause of all deaths in the U.S. 2
  • Lung cancer is the leading cancer killer in every ethnic group2 and since 1987 has killed more women every year than breast cancer.3
  • The five-year survival rate for lung cancer has changed little in nearly 40 years – from 12 percent in 1970 to 17 percent today.4
  • NSCLC is the most common form of lung cancer, accounting for about 85 percent of all diagnoses.5 

This staggering loss of life has gone unnoticed too long, and the ALCF is on a mission to change the statistics.  The ALCF funds clinical research that may lead to potentially life-saving discoveries and treatments and provides critical support services and educational programs to empowe
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.; Bonnie J. Addario Lung Cancer Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
2. New Boehringer Ingelheim Oncology Data to be Presented at ESMO 2012 Congress
3. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
4. Boehringer Laboratories LLC Awarded HPG Contract for Clinical Suction Regulators
5. Ventana to collaborate with Boehringer Ingelheim on the development of companion diagnostic tests
6. Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood
7. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
8. APCER Pharma Sponsors Major Industry Conference
9. Janssen Research & Development, LLC, Sponsors First of its Kind Research Initiative to Advance Multiple Sclerosis Science
10. MO BIO Laboratories, Inc. Becomes Exclusive Sponsor Of Natures Human Microbiota Special
11. Pinnaclife To Sponsor The Nebraska Academy of Nutrition and Dietetics Fuel Up With Color 5K And 1 Mile Fun Run
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... -- Research and Markets  has announced the addition ... Industry Analysis, Size, Share, Growth, Trends and Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 Transfection is a ... RNA) into cells. This technology helps the cells to ... metabolism by affecting the nuclear genes. The transfection technology ...
(Date:7/11/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its new ... GLOBAL MARKETS , the global market for digital polymerase ... 2013. This is estimated to grow to $490 billion ... (CAGR) of 28.6%. , New digital PCR technology has ... the broader PCR field. The opportunities presented by this ...
(Date:7/11/2014)... EPFL and the University of  Geneva ... John P. Donoghue . The American neuroscientist is ... . The new Wyss Center for Bio- ... Geneva , has named as its director one ... Donoghue , founder of Brown University,s Institute for Brain ...
(Date:7/11/2014)... 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today ... acetate) for use as a once-daily adjunctive therapy for ... who are not satisfactorily controlled with conventional therapy.  APTIOM ... under 18 years of age. Epilepsy ... according to Epilepsy Canada, it affects 0.6% of the ...
Breaking Biology Technology:International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4
... allow AIDS viruses to escape detection by the immune ... after transmission to new hosts, scientists at the University ... Medicine. , ,The discovery may help researchers design vaccines ... the immune system to attack the virus where it's ...
... International, Inc. announced Tuesday Herbert Conrad as chairman of the ... on the board of directors. , , ... of Hoffmann-La Roche, Inc. He served as the chairman of ... 2003, and was a co-founder of Reliant Pharmaceuticals in addition ...
... Inc., , Wisconsin-based online clothing retailer, introduced Thursday an updated ... take the guesswork out of online shopping. , ,The new ... women find clothes that fit correctly by modeling garments virtually. ... model that closely resembles the customer. , ,Our customers tell ...
Cached Biology Technology:Studies Offer New Insight into HIV Vaccine Development 2
(Date:7/11/2014)... that under the normal circumstances, astrocytes participate ... neuronal environment, and exhibit therapeutic and repairing ... Previous studies have found that nerve cells ... induction have reduced viability, which produces influences ... Yuan, Kailuan General Hospital, Hebei United University, ...
(Date:7/11/2014)... study the proteins that let nerve cells send out ... upon a biological tactic that may offer a new ... safe and environmentally responsible way. , Their findingthat ... species and harmless for a closely related onesuggests that ... harming beneficial species like bees. A summary of the ...
(Date:7/10/2014)... June 27, 2014  The American Academy of ... of Standards and Technology (NIST) and the Department ... research and forensic science expert members to the ... an element of the NIST,s Organization of Scientific ... the first appointments made to the new FSSB ...
Breaking Biology News(10 mins):Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3
... SAN DIEGO, Calif. (March 9, 2009)The so-called "male ... canceris as effective as surgery in destroying diseased ... for patients of all risk levels and particularly ... released at the Society of Interventional Radiology,s 34th ...
... DIEGO, Calif. (March 9, 2009)A minimally invasive interventional ... relieve the pain of herniated diskswill become standard ... years, predict researchers at the Society of Interventional ... study, the interventional radiologists examined just how ozone ...
... (March 9, 2009)Osteoplastya highly effective minimally invasive ... metastatic bone disease by injecting bone cement ... pain relief, often presenting individuals who are ... effect," according to researchers at the Society ...
Cached Biology News:Freezing prostate cancer does a man's body good 2Freezing prostate cancer does a man's body good 3Freezing prostate cancer does a man's body good 4Freezing prostate cancer does a man's body good 5Oh, my aching back: Give me a shot of ozone 2Oh, my aching back: Give me a shot of ozone 3Metastatic bone disease patients can walk in Lazarus' footsteps 2Metastatic bone disease patients can walk in Lazarus' footsteps 3
Cultrex 3D Culture Matrix Laminin I....
...
...
... Vector NTI Suite for Mac OS X ... for DNA and protein sequence analysis and ... OS X (Table 1). With Vector NTI ... transform share and publicize diverse types of ...
Biology Products: